Literature DB >> 17130328

Minor infection encouraged by steroid administration during cardiac surgery.

Tetsuro Sano1, Shigeki Morita, Munetaka Masuda, Hisataka Yasui.   

Abstract

The aim of this study was to investigate whether steroid administration would increase the risk of postoperative infection. Sixty adults who underwent elective cardiac surgery under cardiopulmonary bypass were prospectively randomized into two groups. Thirty-one patients received hydrocortisone (50 mg x kg(-1)) before and after cardiopulmonary bypass, the other 29 served as controls. Various hemodynamic and pulmonary measurements were obtained perioperatively, and the white blood cell counts and levels of C-reactive protein were checked up to the 14(th) postoperative day. Steroid administration did not have any favorable effects during the perioperative period. Re-administration of antibiotics was needed in 7 patients (22.6%) after the 7(th) postoperative day in the steroid group, and in 3 (10.3%) in the control group. The peak white cell counts and C-reactive protein levels after the 7(th) postoperative day were significantly higher in the steroid group. Steroid administration offered no clinical benefit to patients undergoing cardiac surgery with cardiopulmonary bypass, and it may encourage minor infections in the late postoperative period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130328     DOI: 10.1177/021849230601400613

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  2 in total

1.  Meta-Analysis: Shouldn't Prophylactic Corticosteroids be Administered During Cardiac Surgery with Cardiopulmonary Bypass?

Authors:  Tianci Chai; Xinghui Zhuang; Mengyue Tian; Xiaojie Yang; Zhihuang Qiu; Shurong Xu; Meiling Cai; Yanjuan Lin; Liangwan Chen
Journal:  Front Surg       Date:  2022-06-01

2.  Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial.

Authors:  Gordana Taleska Stupica; Maja Sostaric; Marija Bozhinovska; Lea Rupert; Zoran Bosnic; Ales Jerin; Alojz Ihan; Tomislav Klokocovnik; Matej Podbregar
Journal:  Cardiovasc Ther       Date:  2020-03-27       Impact factor: 3.023

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.